Moving forward, it is essential to elucidate the regulatory mechanisms of HO-1 as a potent antioxidant, address the limitations of HO-1-targeted therapies for periodontitis treatment, and ultimately achieve the clinical application of these drugs as innovative therapeutic agents for periodontitis. The gene discussed is HMOX1; the disease is periodontitis.